Vice Chancellor for Research
Steven R. Goodman, PhD became the Vice Chancellor for Research at the University of Tennessee Health Science Center (UTHSC) effective July 27, 2015. Dr. Goodman is also a Professor in the Department of Pediatrics and the Department of Physiology in the College of Medicine, Professor in the Department of Bioscience Research in the College of Dentistry, and Professor in the College of Nursing at UTHSC. Over his first year in the VCR role he has led the writing of the UTHSC Operational Strategic Plan for Research, the Allocation of Research Space Plan, Business Plans for all Institutional Research Cores, and has participated in discussions on the development of a Bioincubator and Research Park at UTHSC.
Dr. Goodman is the former Vice President for Research and Dean of the College of Graduate Studies at SUNY Upstate Medical University, where he also served as Professor in the Departments of Biochemistry and Molecular Biology and Pediatrics. In his prior role as VPR for Research at SUNY Upstate Medical University his entrepreneurial activity included hiring an Associate VP for Industry Relations, establishing a Tech Transfer Office (TTO) and hiring its Director, launching a process and patent committee to handle New Technology Disclosures, and Co-Chairing the Board for the new BioAccelerator called the Central New York BioAccelerator (CNY BAC) and hiring its Executive Director. The new CNY BAC, which Dr. Goodman helped design, houses startup companies. He also created and directed the International Institute of Biomedical Sciences and Technology (IIBMST).
While at SUNY, Dr. Goodman helped create two additional research collaborations. SUNY REACH, a highly successful research collaboration between the SUNY Academic Health Centers and College of Optometry, served as the model for the current SUNY Network of Excellence in Health. The Hill Collaboration in Environmental Medicine was the shared vision of the Vice Presidents for Research for SUNY Upstate Medical University, Syracuse University, SUNY ESF and the Syracuse VA Medical Center. Dr. Goodman directed SUNY REACH and co-directed the Hill Collaboration.
Dr. Goodman arrived in New York from the University of Texas at Dallas where he served as the C.L. and Amelia A. Lundell Professor of Life Sciences, Professor and Head of the Department of Molecular and Cell Biology, Director of the Institute of Biomedical Sciences and Technology (IBMST), and Director of the Sickle Cell Disease Research Center. He was also an adjunct Professor in the Department of Cell Biology at UT Southwestern Medical Center. Together with Dr. George Buchanan and other colleagues at UT Southwestern Medical Center, Dr. Goodman helped bring the first NIH Sickle Cell Center to Texas. Prior to his positions in Dallas, Dr. Goodman was chair of the Department of Cell Biology and Neuroscience and Director of the NIH Comprehensive Sickle Cell Center at the University of South Alabama College of Medicine.
Dr. Goodman is respected worldwide for his three-plus decades of research into the structure and function of cell structures called membrane skeletons. His related research into sickle cell disease led to defining the molecular basis of the irreversibly sickled cell and his recent proteomic studies led to potential biomarkers for sickle cell severity. He has published over 160 peer-reviewed research articles, review articles, and book chapters and another 130 scientific meeting abstracts. His research has garnered approximately $20 million of extramural support. He is a past President of the Association of Anatomy, Cell Biology and Neurobiology Chairs (AACBNC) and a recipient of the Society of Experimental Biology and Medicine (SEBM) Distinguished Scientist Award. The third edition of Dr. Goodman's textbook, Medical Cell Biology, was published in 2008.
Dr. Goodman serves on multiple editorial boards and has been Editor-in-Chief of Experimental Biology and Medicine (EBM) since July 2006. Since becoming Editor-in-Chief of EBM, Dr. Goodman has globalized SEBM and EBM, opening offices in Tainan, London and most recently Chengdu, China. These are in addition to the SEBM office in the Washington DC area and the EBM office in New York City.